Tyra Biosciences (TYRA) Competitors $10.09 +0.07 (+0.70%) As of 04/24/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TYRA vs. AAPG, TARS, JANX, BEAM, ARWR, HRMY, GMTX, KYMR, GLPG, and BHCShould you be buying Tyra Biosciences stock or one of its competitors? The main competitors of Tyra Biosciences include Ascentage Pharma Group International (AAPG), Tarsus Pharmaceuticals (TARS), Janux Therapeutics (JANX), Beam Therapeutics (BEAM), Arrowhead Pharmaceuticals (ARWR), Harmony Biosciences (HRMY), Gemini Therapeutics (GMTX), Kymera Therapeutics (KYMR), Galapagos (GLPG), and Bausch Health Companies (BHC). These companies are all part of the "pharmaceutical products" industry. Tyra Biosciences vs. Ascentage Pharma Group International Tarsus Pharmaceuticals Janux Therapeutics Beam Therapeutics Arrowhead Pharmaceuticals Harmony Biosciences Gemini Therapeutics Kymera Therapeutics Galapagos Bausch Health Companies Ascentage Pharma Group International (NASDAQ:AAPG) and Tyra Biosciences (NASDAQ:TYRA) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, earnings, risk, profitability, institutional ownership, dividends, valuation and community ranking. Does the MarketBeat Community favor AAPG or TYRA? Tyra Biosciences received 35 more outperform votes than Ascentage Pharma Group International when rated by MarketBeat users. However, 100.00% of users gave Ascentage Pharma Group International an outperform vote while only 76.60% of users gave Tyra Biosciences an outperform vote. CompanyUnderperformOutperformAscentage Pharma Group InternationalOutperform Votes1100.00% Underperform VotesNo VotesTyra BiosciencesOutperform Votes3676.60% Underperform Votes1123.40% Which has higher earnings & valuation, AAPG or TYRA? Ascentage Pharma Group International has higher revenue and earnings than Tyra Biosciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAscentage Pharma Group International$980.65M2.26N/AN/AN/ATyra BiosciencesN/AN/A-$69.13M-$1.51-6.68 Do institutionals & insiders have more ownership in AAPG or TYRA? 84.1% of Tyra Biosciences shares are held by institutional investors. 15.4% of Tyra Biosciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Is AAPG or TYRA more profitable? Ascentage Pharma Group International's return on equity of 0.00% beat Tyra Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Ascentage Pharma Group InternationalN/A N/A N/A Tyra Biosciences N/A -24.56%-23.31% Do analysts rate AAPG or TYRA? Tyra Biosciences has a consensus price target of $30.83, suggesting a potential upside of 205.58%. Given Tyra Biosciences' higher probable upside, analysts clearly believe Tyra Biosciences is more favorable than Ascentage Pharma Group International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ascentage Pharma Group International 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Tyra Biosciences 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media prefer AAPG or TYRA? In the previous week, Ascentage Pharma Group International had 1 more articles in the media than Tyra Biosciences. MarketBeat recorded 4 mentions for Ascentage Pharma Group International and 3 mentions for Tyra Biosciences. Tyra Biosciences' average media sentiment score of 1.59 beat Ascentage Pharma Group International's score of 0.31 indicating that Tyra Biosciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ascentage Pharma Group International 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Tyra Biosciences 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive SummaryTyra Biosciences beats Ascentage Pharma Group International on 6 of the 11 factors compared between the two stocks. Get Tyra Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for TYRA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TYRA vs. The Competition Export to ExcelMetricTyra BiosciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$535.68M$6.59B$5.40B$7.70BDividend YieldN/A3.20%5.44%4.32%P/E Ratio-6.277.0522.2418.31Price / SalesN/A273.45402.05107.05Price / CashN/A65.6738.2034.62Price / Book2.136.506.844.25Net Income-$69.13M$142.50M$3.20B$247.51M7 Day Performance13.12%8.32%5.91%6.33%1 Month Performance-2.13%-5.61%-4.20%-3.33%1 Year Performance-33.22%0.11%18.03%5.15% Tyra Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TYRATyra Biosciences2.0615 of 5 stars$10.09+0.7%$30.83+205.6%-36.9%$535.68MN/A-6.2720Positive NewsAAPGAscentage Pharma Group InternationalN/A$20.49+9.6%N/AN/A$1.78B$980.65M0.00600Gap UpTARSTarsus Pharmaceuticals2.1576 of 5 stars$48.72+4.9%$63.67+30.7%+52.5%$1.78B$182.95M-12.7950News CoveragePositive NewsJANXJanux Therapeutics2.6747 of 5 stars$28.95+0.5%$92.44+219.3%-33.5%$1.71B$10.59M-24.7430Insider TradePositive NewsBEAMBeam Therapeutics2.9468 of 5 stars$17.00+9.9%$49.45+190.9%-11.3%$1.70B$63.52M-9.66510Options VolumeHigh Trading VolumeARWRArrowhead Pharmaceuticals3.4925 of 5 stars$12.34+4.7%$41.44+235.9%-42.7%$1.69B$2.50M-2.39400Positive NewsHRMYHarmony Biosciences4.6992 of 5 stars$29.53+1.2%$53.33+80.6%+0.7%$1.69B$714.73M14.00200Upcoming EarningsPositive NewsGMTXGemini TherapeuticsN/A$38.73+9.9%N/A+67.2%$1.68BN/A-38.7330Gap UpHigh Trading VolumeKYMRKymera Therapeutics1.2024 of 5 stars$25.43+5.4%$56.36+121.6%-4.7%$1.65B$47.07M-10.87170Upcoming EarningsGLPGGalapagos0.6511 of 5 stars$24.20+0.8%$25.33+4.7%-7.9%$1.59B$275.65M0.001,310Earnings ReportHigh Trading VolumeBHCBausch Health Companies4.1133 of 5 stars$4.33+0.2%$7.17+65.5%-36.1%$1.59B$9.63B-36.0819,900Upcoming EarningsAnalyst Downgrade Related Companies and Tools Related Companies AAPG Alternatives TARS Alternatives JANX Alternatives BEAM Alternatives ARWR Alternatives HRMY Alternatives GMTX Alternatives KYMR Alternatives GLPG Alternatives BHC Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TYRA) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tyra Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tyra Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TYRA Stock Free TYRA Stock Alerts